BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32667714)

  • 21. The anti-breast cancer potential of indole/isatin hybrids.
    Wang R; Huang R; Yuan Y; Wang Z; Shen K
    Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300402. PubMed ID: 37650315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One Pot Synthesis and Biological Activity Studies of New Spirooxindoles.
    Omidvar AR; Asghari S; Ghasempour L; Mohseni M
    Chem Biodivers; 2024 Jun; 21(6):e202301942. PubMed ID: 38393713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
    Cai S; Yuan W; Li Y; Huang X; Guo Q; Tang Z; Fang Z; Lin H; Wong WL; Wong KY; Lu YJ; Sun N
    Bioorg Med Chem; 2019 Apr; 27(7):1274-1282. PubMed ID: 30792100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and pharmacological characterization of isatin and its derivatives: from structure to activity.
    Pakravan P; Kashanian S; Khodaei MM; Harding FJ
    Pharmacol Rep; 2013; 65(2):313-35. PubMed ID: 23744416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of indole-based peptidomimetics as antibacterial agents against Gram-positive bacteria.
    Chen Y; Li H; Liu J; Zhong R; Li H; Fang S; Liu S; Lin S
    Eur J Med Chem; 2021 Dec; 226():113813. PubMed ID: 34520955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isatin-azole hybrids and their anticancer activities.
    Hou Y; Shang C; Wang H; Yun J
    Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900272. PubMed ID: 31691360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural indole-containing alkaloids and their antibacterial activities.
    Liu Y; Cui Y; Lu L; Gong Y; Han W; Piao G
    Arch Pharm (Weinheim); 2020 Oct; 353(10):e2000120. PubMed ID: 32557757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial and mutagenic properties of organotin(IV) complexes with isatin and N-alkylisatin bisthiocarbonohydrazones.
    Bacchi A; Carcelli M; Pelagatti P; Pelizzi G; Rodriguez-Arguelles MC; Rogolino D; Solinas C; Zani F
    J Inorg Biochem; 2005 Feb; 99(2):397-408. PubMed ID: 15621271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Mini Review on Pharmacological Significance of Isatin-1,2,3-Triazole Hybrids.
    Kumar A; Rohila Y; Kumar V; Lal K
    Curr Top Med Chem; 2023; 23(10):833-847. PubMed ID: 36733194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacophore Modeling and 3D-QSAR Study of Indole and Isatin Derivatives as Antiamyloidogenic Agents Targeting Alzheimer's Disease.
    Purgatorio R; Gambacorta N; Catto M; de Candia M; Pisani L; Espargaró A; Sabaté R; Cellamare S; Nicolotti O; Altomare CD
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33297547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial and antifungal activities of isatin N-Mannich bases.
    Kupinić M; Medić-Sarić M; Movrin M; Maysinger D
    J Pharm Sci; 1979 Apr; 68(4):459-62. PubMed ID: 438969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in isatin hybrids as potential anticancer agents.
    Ding Z; Zhou M; Zeng C
    Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900367. PubMed ID: 31960987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant
    Elsayed ZM; Eldehna WM; Abdel-Aziz MM; El Hassab MA; Elkaeed EB; Al-Warhi T; Abdel-Aziz HA; Abou-Seri SM; Mohammed ER
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):384-393. PubMed ID: 33406941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and characterization of some new bishydrazones derived from isatin.
    Tătărîngă G; Dorneanu O; Stefănescu E; Dorneanu M
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):246-8. PubMed ID: 18677935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel indole-thiazolidinone conjugates: Design, synthesis and whole-cell phenotypic evaluation as a novel class of antimicrobial agents.
    Abo-Ashour MF; Eldehna WM; George RF; Abdel-Aziz MM; Elaasser MM; Abdel Gawad NM; Gupta A; Bhakta S; Abou-Seri SM
    Eur J Med Chem; 2018 Dec; 160():49-60. PubMed ID: 30317025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
    Plech T; Wujec M; Kosikowska U; Malm A; Rajtar B; Polz-Dacewicz M
    Eur J Med Chem; 2013 Feb; 60():128-34. PubMed ID: 23287058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, characterization, and antimicrobial activity of some new N-aryl-N'-(2-oxoindolin-3-ylidene)-benzohydrazonamides.
    Gomaa MA; Hassan DK
    Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900209. PubMed ID: 31621127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential antimicrobial agents--I: Structural modifications and antimicrobial activity of some isatin derivatives.
    Ali S; Alam M
    Arch Pharm Res; 1994 Apr; 17(2):131-3. PubMed ID: 10319145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
    Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
    Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel cajaninstilbene acid derivatives as antibacterial agents.
    Geng ZZ; Zhang JJ; Lin J; Huang MY; An LK; Zhang HB; Sun PH; Ye WC; Chen WM
    Eur J Med Chem; 2015 Jul; 100():235-45. PubMed ID: 26093280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.